NDC 58468-7860

CAPRELSA

Vandetanib

CAPRELSA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Genzyme Corporation. The primary component is Vandetanib.

• Product ID: 58468-7860_a8442300-a9bd-466b-ae0c-57531cf15820
• NDC: 58468-7860
• Product Type: Human Prescription Drug
• Proprietary Name: CAPRELSA
• Generic Name: Vandetanib
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-06-24
• Marketing Category: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE /
• Labeler Name: Genzyme Corporation
• Substance Name: VANDETANIB
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: Kinase Inhibitor [EPC], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 58468-7860-3

3 BLISTER PACK in 1 CARTON (58468-7860-3) > 10 TABLET, FILM COATED in 1 BLISTER PACK

• Marketing Start Date: 2022-06-24
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "CAPRELSA" or generic name "Vandetanib"

NDC	Brand Name	Generic Name
0310-7820	CAPRELSA	Vandetanib
0310-7840	CAPRELSA	Vandetanib
58468-7820	CAPRELSA	Vandetanib
58468-7840	CAPRELSA	Vandetanib
58468-7860	CAPRELSA	Vandetanib